Correlation Between ABVC Biopharma and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Indaptus Therapeutics, you can compare the effects of market volatilities on ABVC Biopharma and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Indaptus Therapeutics.
Diversification Opportunities for ABVC Biopharma and Indaptus Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between ABVC and Indaptus is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Indaptus Therapeutics
Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Indaptus Therapeutics. In addition to that, ABVC Biopharma is 1.51 times more volatile than Indaptus Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Indaptus Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 183.00 in Indaptus Therapeutics on October 24, 2024 and sell it today you would lose (97.00) from holding Indaptus Therapeutics or give up 53.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ABVC Biopharma vs. Indaptus Therapeutics
Performance |
| Timeline |
| ABVC Biopharma |
| Indaptus Therapeutics |
ABVC Biopharma and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Indaptus Therapeutics
The main advantage of trading using opposite ABVC Biopharma and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Akari Therapeutics PLC |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |